Tenax Therapeutics Ownership 2024 | Who Owns Tenax Therapeutics Now?
Institutional Ownership
1.31%
Insider Ownership
0.33%
Retail Ownership
98.37%
Institutional Holders
15.00
Tenax Therapeutics Institutional Shareholders
Institutional Shareholders by % of Total Shares
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
CI PRIVATE WEALTH, LLC | 13.62% | 0.00% | 191,460 | 191,460 | 100.00% | 89,029,000 | Mar 31, 2023 |
STATE STREET CORP | 6.77% | - | 95,122 | 95,122 | 100.00% | 44,232,000 | Mar 31, 2023 |
VIRTU FINANCIAL LLC | 6.00% | 0.00% | 84,361 | 84,361 | 100.00% | 39,000 | Mar 31, 2023 |
VERITION FUND MANAGEMENT LLC | 3.10% | 0.00% | 43,579 | 43,579 | 100.00% | 20,264,000 | Mar 31, 2023 |
TWO SIGMA SECURITIES, LLC | 3.06% | 0.00% | 42,995 | 42,995 | 100.00% | 19,993,000 | Mar 31, 2023 |
BLACKROCK INC. | 1.70% | - | 23,922 | 23,922 | 100.00% | 11,124,000 | Mar 31, 2023 |
AVANTAX PLANNING PARTNERS, INC. | 0.71% | 0.00% | 10,002 | 10,002 | 100.00% | 4,651,000 | Mar 31, 2023 |
TOWER RESEARCH CAPITAL LLC (TRC) | 0.33% | 0.00% | 4,697 | 4,697 | 100.00% | 2,000 | Mar 31, 2023 |
MORGAN STANLEY | 0.05% | - | 680 | 680 | 100.00% | 316,000 | Mar 31, 2023 |
WELLS FARGO & COMPANY/MN | 0.00% | - | 64 | 64 | 100.00% | 30,000 | Mar 31, 2023 |
TUCKER ASSET MANAGEMENT LLC | 0.00% | - | 2 | 2 | 100.00% | 1,000 | Mar 31, 2023 |
ALLWORTH FINANCIAL LP | 0.00% | - | 1 | 1 | 100.00% | 1,000 | Mar 31, 2023 |
WELLS FARGO & COMPANY/MN | - | - | - | -13 | -100.00% | - | Mar 31, 2023 |
UBS GROUP AG | - | - | - | -8,049 | -100.00% | - | Mar 31, 2023 |
BLACKROCK INC. | - | - | - | -23,954 | -100.00% | - | Mar 31, 2023 |
NORTHERN TRUST CORP | - | - | - | -1,734 | -100.00% | - | Mar 31, 2023 |
MORGAN STANLEY | - | - | - | -680 | -100.00% | - | Mar 31, 2023 |
STATE STREET CORP | - | - | - | -6,921 | -100.00% | - | Mar 31, 2023 |
RENAISSANCE TECHNOLOGIES LLC | - | - | - | -3,169 | -100.00% | - | Mar 31, 2023 |
ACADIAN ASSET MANAGEMENT LLC | - | - | - | -60,501 | -100.00% | - | Mar 31, 2023 |
Tenax Therapeutics's largest institutional shareholder is CI PRIVATE WEALTH, LLC, holding 13.62% of the company's total share outstanding, currently valued at $89.03M. The top 10 institutional shareholders own together 35.34% of the company.
Institutional Shareholders by % of Total Assets
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
VIRTU FINANCIAL LLC | 6.00% | 0.00% | 84,361 | 84,361 | 100.00% | 39,000 | Mar 31, 2023 |
TWO SIGMA SECURITIES, LLC | 3.06% | 0.00% | 42,995 | 42,995 | 100.00% | 19,993,000 | Mar 31, 2023 |
VERITION FUND MANAGEMENT LLC | 3.10% | 0.00% | 43,579 | 43,579 | 100.00% | 20,264,000 | Mar 31, 2023 |
CI PRIVATE WEALTH, LLC | 13.62% | 0.00% | 191,460 | 191,460 | 100.00% | 89,029,000 | Mar 31, 2023 |
AVANTAX PLANNING PARTNERS, INC. | 0.71% | 0.00% | 10,002 | 10,002 | 100.00% | 4,651,000 | Mar 31, 2023 |
TOWER RESEARCH CAPITAL LLC (TRC) | 0.33% | 0.00% | 4,697 | 4,697 | 100.00% | 2,000 | Mar 31, 2023 |
STATE STREET CORP | 6.77% | - | 95,122 | 95,122 | 100.00% | 44,232,000 | Mar 31, 2023 |
BLACKROCK INC. | 1.70% | - | 23,922 | 23,922 | 100.00% | 11,124,000 | Mar 31, 2023 |
TUCKER ASSET MANAGEMENT LLC | 0.00% | - | 2 | 2 | 100.00% | 1,000 | Mar 31, 2023 |
MORGAN STANLEY | 0.05% | - | 680 | 680 | 100.00% | 316,000 | Mar 31, 2023 |
ALLWORTH FINANCIAL LP | 0.00% | - | 1 | 1 | 100.00% | 1,000 | Mar 31, 2023 |
WELLS FARGO & COMPANY/MN | 0.00% | - | 64 | 64 | 100.00% | 30,000 | Mar 31, 2023 |
MORGAN STANLEY | - | - | - | -680 | -100.00% | - | Mar 31, 2023 |
BLACKROCK INC. | - | - | - | -23,954 | -100.00% | - | Mar 31, 2023 |
NORTHERN TRUST CORP | - | - | - | -1,734 | -100.00% | - | Mar 31, 2023 |
STATE STREET CORP | - | - | - | -6,921 | -100.00% | - | Mar 31, 2023 |
RENAISSANCE TECHNOLOGIES LLC | - | - | - | -3,169 | -100.00% | - | Mar 31, 2023 |
ACADIAN ASSET MANAGEMENT LLC | - | - | - | -60,501 | -100.00% | - | Mar 31, 2023 |
HRT FINANCIAL LP | - | - | - | -1,293 | -100.00% | - | Mar 31, 2023 |
TOWER RESEARCH CAPITAL LLC (TRC) | - | - | - | -477 | -100.00% | - | Mar 31, 2023 |
The largest Tenax Therapeutics shareholder by % of total assets is VIRTU FINANCIAL LLC. The company owns 84.36K shares of Tenax Therapeutics (TENX), representing 0.00% of its total assets.
Institutional Buyers
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
CI PRIVATE WEALTH, LLC | 13.62% | 0.00% | 191,460 | 191,460 | 100.00% | 89,029,000 | Mar 31, 2023 |
STATE STREET CORP | 6.77% | - | 95,122 | 95,122 | 100.00% | 44,232,000 | Mar 31, 2023 |
VIRTU FINANCIAL LLC | 6.00% | 0.00% | 84,361 | 84,361 | 100.00% | 39,000 | Mar 31, 2023 |
VERITION FUND MANAGEMENT LLC | 3.10% | 0.00% | 43,579 | 43,579 | 100.00% | 20,264,000 | Mar 31, 2023 |
TWO SIGMA SECURITIES, LLC | 3.06% | 0.00% | 42,995 | 42,995 | 100.00% | 19,993,000 | Mar 31, 2023 |
BLACKROCK INC. | 1.70% | - | 23,922 | 23,922 | 100.00% | 11,124,000 | Mar 31, 2023 |
AVANTAX PLANNING PARTNERS, INC. | 0.71% | 0.00% | 10,002 | 10,002 | 100.00% | 4,651,000 | Mar 31, 2023 |
TOWER RESEARCH CAPITAL LLC (TRC) | 0.33% | 0.00% | 4,697 | 4,697 | 100.00% | 2,000 | Mar 31, 2023 |
MORGAN STANLEY | 0.05% | - | 680 | 680 | 100.00% | 316,000 | Mar 31, 2023 |
WELLS FARGO & COMPANY/MN | 0.00% | - | 64 | 64 | 100.00% | 30,000 | Mar 31, 2023 |
TUCKER ASSET MANAGEMENT LLC | 0.00% | - | 2 | 2 | 100.00% | 1,000 | Mar 31, 2023 |
ALLWORTH FINANCIAL LP | 0.00% | - | 1 | 1 | 100.00% | 1,000 | Mar 31, 2023 |
TUCKER ASSET MANAGEMENT LLC | - | - | - | -2 | -100.00% | - | Mar 31, 2023 |
PNC FINANCIAL SERVICES GROUP, INC. | - | - | - | -10 | -100.00% | - | Mar 31, 2023 |
WELLS FARGO & COMPANY/MN | - | - | - | -13 | -100.00% | - | Mar 31, 2023 |
TOWER RESEARCH CAPITAL LLC (TRC) | - | - | - | -477 | -100.00% | - | Mar 31, 2023 |
MORGAN STANLEY | - | - | - | -680 | -100.00% | - | Mar 31, 2023 |
HRT FINANCIAL LP | - | - | - | -1,293 | -100.00% | - | Mar 31, 2023 |
NORTHERN TRUST CORP | - | - | - | -1,734 | -100.00% | - | Mar 31, 2023 |
GEODE CAPITAL MANAGEMENT, LLC | - | - | - | -2,561 | -100.00% | - | Mar 31, 2023 |
As of Mar 31 2023, Tenax Therapeutics's largest institutional buyer is CI PRIVATE WEALTH, LLC. The company purchased 191.46K stocks of TENX, valued at $89.03M.
Institutional Sellers
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
ACADIAN ASSET MANAGEMENT LLC | - | - | - | -60,501 | -100.00% | - | Mar 31, 2023 |
BLACKROCK INC. | - | - | - | -23,954 | -100.00% | - | Mar 31, 2023 |
VANGUARD GROUP INC | - | - | - | -8,691 | -100.00% | - | Mar 31, 2023 |
UBS GROUP AG | - | - | - | -8,049 | -100.00% | - | Mar 31, 2023 |
STATE STREET CORP | - | - | - | -6,921 | -100.00% | - | Mar 31, 2023 |
TWO SIGMA SECURITIES, LLC | - | - | - | -3,387 | -100.00% | - | Mar 31, 2023 |
RENAISSANCE TECHNOLOGIES LLC | - | - | - | -3,169 | -100.00% | - | Mar 31, 2023 |
GEODE CAPITAL MANAGEMENT, LLC | - | - | - | -2,561 | -100.00% | - | Mar 31, 2023 |
NORTHERN TRUST CORP | - | - | - | -1,734 | -100.00% | - | Mar 31, 2023 |
HRT FINANCIAL LP | - | - | - | -1,293 | -100.00% | - | Mar 31, 2023 |
MORGAN STANLEY | - | - | - | -680 | -100.00% | - | Mar 31, 2023 |
TOWER RESEARCH CAPITAL LLC (TRC) | - | - | - | -477 | -100.00% | - | Mar 31, 2023 |
WELLS FARGO & COMPANY/MN | - | - | - | -13 | -100.00% | - | Mar 31, 2023 |
PNC FINANCIAL SERVICES GROUP, INC. | - | - | - | -10 | -100.00% | - | Mar 31, 2023 |
TUCKER ASSET MANAGEMENT LLC | - | - | - | -2 | -100.00% | - | Mar 31, 2023 |
ALLWORTH FINANCIAL LP | 0.00% | - | 1 | 1 | 100.00% | 1,000 | Mar 31, 2023 |
TUCKER ASSET MANAGEMENT LLC | 0.00% | - | 2 | 2 | 100.00% | 1,000 | Mar 31, 2023 |
WELLS FARGO & COMPANY/MN | 0.00% | - | 64 | 64 | 100.00% | 30,000 | Mar 31, 2023 |
MORGAN STANLEY | 0.05% | - | 680 | 680 | 100.00% | 316,000 | Mar 31, 2023 |
TOWER RESEARCH CAPITAL LLC (TRC) | 0.33% | 0.00% | 4,697 | 4,697 | 100.00% | 2,000 | Mar 31, 2023 |
As of Mar 31 2023, Tenax Therapeutics's biggest institutional seller is ACADIAN ASSET MANAGEMENT LLC. The company sold -60.50K shares of TENX, valued at -.
Institutional New positions
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
CI PRIVATE WEALTH, LLC | 13.62% | 0.00% | 191,460 | 191,460 | 100.00% | 89,029,000 | Mar 31, 2023 |
STATE STREET CORP | 6.77% | - | 95,122 | 95,122 | 100.00% | 44,232,000 | Mar 31, 2023 |
VIRTU FINANCIAL LLC | 6.00% | 0.00% | 84,361 | 84,361 | 100.00% | 39,000 | Mar 31, 2023 |
VERITION FUND MANAGEMENT LLC | 3.10% | 0.00% | 43,579 | 43,579 | 100.00% | 20,264,000 | Mar 31, 2023 |
TWO SIGMA SECURITIES, LLC | 3.06% | 0.00% | 42,995 | 42,995 | 100.00% | 19,993,000 | Mar 31, 2023 |
BLACKROCK INC. | 1.70% | - | 23,922 | 23,922 | 100.00% | 11,124,000 | Mar 31, 2023 |
AVANTAX PLANNING PARTNERS, INC. | 0.71% | 0.00% | 10,002 | 10,002 | 100.00% | 4,651,000 | Mar 31, 2023 |
TOWER RESEARCH CAPITAL LLC (TRC) | 0.33% | 0.00% | 4,697 | 4,697 | 100.00% | 2,000 | Mar 31, 2023 |
MORGAN STANLEY | 0.05% | - | 680 | 680 | 100.00% | 316,000 | Mar 31, 2023 |
WELLS FARGO & COMPANY/MN | 0.00% | - | 64 | 64 | 100.00% | 30,000 | Mar 31, 2023 |
TUCKER ASSET MANAGEMENT LLC | 0.00% | - | 2 | 2 | 100.00% | 1,000 | Mar 31, 2023 |
ALLWORTH FINANCIAL LP | 0.00% | - | 1 | 1 | 100.00% | 1,000 | Mar 31, 2023 |
Tenax Therapeutics's largest new institutional shareholder by number of shares is CI PRIVATE WEALTH, LLC, purchased 191.46K shares, valued at $89.03M, as of undefined.
Institutional Sold Out
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
ACADIAN ASSET MANAGEMENT LLC | - | - | - | -60,501 | -100.00% | - | Mar 31, 2023 |
BLACKROCK INC. | - | - | - | -23,954 | -100.00% | - | Mar 31, 2023 |
VANGUARD GROUP INC | - | - | - | -8,691 | -100.00% | - | Mar 31, 2023 |
UBS GROUP AG | - | - | - | -8,049 | -100.00% | - | Mar 31, 2023 |
STATE STREET CORP | - | - | - | -6,921 | -100.00% | - | Mar 31, 2023 |
TWO SIGMA SECURITIES, LLC | - | - | - | -3,387 | -100.00% | - | Mar 31, 2023 |
RENAISSANCE TECHNOLOGIES LLC | - | - | - | -3,169 | -100.00% | - | Mar 31, 2023 |
GEODE CAPITAL MANAGEMENT, LLC | - | - | - | -2,561 | -100.00% | - | Mar 31, 2023 |
NORTHERN TRUST CORP | - | - | - | -1,734 | -100.00% | - | Mar 31, 2023 |
HRT FINANCIAL LP | - | - | - | -1,293 | -100.00% | - | Mar 31, 2023 |
MORGAN STANLEY | - | - | - | -680 | -100.00% | - | Mar 31, 2023 |
TOWER RESEARCH CAPITAL LLC (TRC) | - | - | - | -477 | -100.00% | - | Mar 31, 2023 |
WELLS FARGO & COMPANY/MN | - | - | - | -13 | -100.00% | - | Mar 31, 2023 |
PNC FINANCIAL SERVICES GROUP, INC. | - | - | - | -10 | -100.00% | - | Mar 31, 2023 |
TUCKER ASSET MANAGEMENT LLC | - | - | - | -2 | -100.00% | - | Mar 31, 2023 |
Tenax Therapeutics's largest sold out institutional shareholder by shares sold is ACADIAN ASSET MANAGEMENT LLC, sold -60.50K shares, valued at -, as of undefined.
Tenax Therapeutics Mutual Fund Holders
Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
---|---|---|---|---|---|
VANGUARD INDEX FUNDS | 0.00% | 372,092 | - | - | Mar 31, 2024 |
FIDELITY CONCORD STREET TRUST | 0.00% | 148,118 | - | - | Feb 29, 2024 |
VANGUARD INDEX FUNDS | 0.00% | 173,801 | - | - | Mar 31, 2024 |
FIDELITY CONCORD STREET TRUST | 0.00% | 51,179 | - | - | Feb 29, 2024 |
DFA INVESTMENT DIMENSIONS GROUP INC | 0.00% | 12,186 | - | - | Jan 31, 2024 |
EQ ADVISORS TRUST | 0.00% | 2,134 | - | - | Mar 31, 2024 |
Tenax Therapeutics's largest mutual fund holder by % of total assets is "VANGUARD INDEX FUNDS", owning 372.09K shares, compromising 0.00% of its total assets.
Tenax Therapeutics Institutional Ownership Trends
Institutional Holdings Trend
Date | Holdings | Change % |
---|---|---|
31 Dec, 22 | 15 | -25.00% |
30 Sep, 22 | 20 | 33.33% |
30 Jun, 22 | 15 | - |
31 Mar, 22 | 15 | -6.25% |
31 Dec, 21 | 16 | 14.29% |
30 Sep, 21 | 14 | -12.50% |
30 Jun, 21 | 16 | 6.67% |
31 Mar, 21 | 15 | -6.25% |
31 Dec, 20 | 16 | 6.67% |
30 Sep, 20 | 15 | -11.76% |
30 Jun, 20 | 17 | 88.89% |
31 Mar, 20 | 9 | -10.00% |
31 Dec, 19 | 10 | -16.67% |
30 Sep, 19 | 12 | 20.00% |
30 Jun, 19 | 10 | 11.11% |
31 Mar, 19 | 9 | -10.00% |
31 Dec, 18 | 10 | 66.67% |
30 Sep, 18 | 6 | -25.00% |
30 Jun, 18 | 8 | 14.29% |
31 Mar, 18 | 7 | - |
As of 31 Dec 22, 15 institutions are holding Tenax Therapeutics's shares, representing a decrease of -25.00% compared to the previous quarter.
Shares Outstanding Trend
Date | Shares Outstanding | Change % |
---|---|---|
31 Dec, 22 | 2,428,685 | -66.66% |
30 Sep, 22 | 7,283,589 | 5.12% |
30 Jun, 22 | 6,928,902 | -14.27% |
31 Mar, 22 | 8,082,294 | 0.25% |
31 Dec, 21 | 8,062,390 | 4.55% |
30 Sep, 21 | 7,711,585 | 120.01% |
30 Jun, 21 | 3,505,165 | -7.67% |
31 Mar, 21 | 3,796,316 | 12.40% |
31 Dec, 20 | 3,377,498 | -16.63% |
30 Sep, 20 | 4,051,309 | 76.18% |
30 Jun, 20 | 2,299,515 | 49.91% |
31 Mar, 20 | 1,533,971 | 23.74% |
31 Dec, 19 | 1,239,642 | 1.85% |
30 Sep, 19 | 1,217,178 | 7.33% |
30 Jun, 19 | 1,134,079 | 12.47% |
31 Mar, 19 | 1,008,372 | 96.12% |
31 Dec, 18 | 514,159 | 191.74% |
30 Sep, 18 | 176,237 | 1.56% |
30 Jun, 18 | 173,534 | 9.53% |
31 Mar, 18 | 158,432 | - |
Tenax Therapeutics (TENX) has 2.43M shares outstanding as of 31 Dec 22, down -66.66% compared to the previous quarter.
Institutional Ownership Trend
Date | Ownership % | Change % |
---|---|---|
31 Dec, 22 | 1.31% | 8.51% |
30 Sep, 22 | 3.92% | 28.22% |
30 Jun, 22 | 3.72% | 19.73% |
31 Mar, 22 | 4.34% | 23.13% |
31 Dec, 21 | 4.33% | 25.22% |
30 Sep, 21 | 4.15% | 65.65% |
30 Jun, 21 | 2.51% | 33.92% |
31 Mar, 21 | 2.72% | 46.42% |
31 Dec, 20 | 2.42% | 28.70% |
30 Sep, 20 | 2.90% | 106.87% |
30 Jun, 20 | 1.65% | 136.32% |
31 Mar, 20 | 1.10% | 139.24% |
31 Dec, 19 | 0.89% | 116.72% |
30 Sep, 19 | 0.87% | 64.82% |
30 Jun, 19 | 1.16% | 109.01% |
31 Mar, 19 | 1.03% | 372.85% |
31 Dec, 18 | 0.53% | 1618.08% |
30 Sep, 18 | 0.18% | 572.17% |
30 Jun, 18 | 0.18% | 675.69% |
31 Mar, 18 | 0.16% | - |
As of 31 Dec 22, Tenax Therapeutics is held by 1.31% institutional shareholders, representing a 8.51% growth compared to 30 Sep 22.
Institutional Increased Positions Trend
Date | Increased Positions | Change % |
---|---|---|
31 Dec, 22 | 6 | -50.00% |
30 Sep, 22 | 12 | 140.00% |
30 Jun, 22 | 5 | 66.67% |
31 Mar, 22 | 3 | -57.14% |
31 Dec, 21 | 7 | 16.67% |
30 Sep, 21 | 6 | -25.00% |
30 Jun, 21 | 8 | 60.00% |
31 Mar, 21 | 5 | - |
31 Dec, 20 | 5 | -16.67% |
30 Sep, 20 | 6 | -53.85% |
30 Jun, 20 | 13 | 333.33% |
31 Mar, 20 | 3 | -25.00% |
31 Dec, 19 | 4 | -33.33% |
30 Sep, 19 | 6 | 50.00% |
30 Jun, 19 | 4 | - |
31 Mar, 19 | 4 | -42.86% |
31 Dec, 18 | 7 | 600.00% |
30 Sep, 18 | 1 | -80.00% |
30 Jun, 18 | 5 | -28.57% |
31 Mar, 18 | 7 | - |
6 institutional shareholders have increased their position in TENX stock as of 31 Dec 22 compared to 12 in the previous quarter (a -50.00% decrease).
Institutional Reduced Positions Trend
Date | Reduced Positions | Change % |
---|---|---|
31 Dec, 22 | 4 | 300.00% |
30 Sep, 22 | 1 | -66.67% |
30 Jun, 22 | 3 | -25.00% |
31 Mar, 22 | 4 | 100.00% |
31 Dec, 21 | 2 | - |
30 Sep, 21 | 2 | -50.00% |
30 Jun, 21 | 4 | 33.33% |
31 Mar, 21 | 3 | -25.00% |
31 Dec, 20 | 4 | 33.33% |
30 Sep, 20 | 3 | 200.00% |
30 Jun, 20 | 1 | -66.67% |
31 Mar, 20 | 3 | - |
31 Dec, 19 | - | - |
30 Sep, 19 | - | -100.00% |
30 Jun, 19 | 3 | 50.00% |
31 Mar, 19 | 2 | 100.00% |
31 Dec, 18 | 1 | - |
30 Sep, 18 | 1 | - |
30 Jun, 18 | 1 | - |
31 Mar, 18 | - | - |
4 institutional shareholders have reduced their position in TENX stock as of 31 Dec 22 compared to 1 in the previous quarter (a 300.00% increase).
All Institutional Ownership Trend Data
Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
---|---|---|---|---|---|---|---|---|---|---|
31 Dec, 22 | 15 | -25.00% | 2,428,685 | -66.66% | 1.31% | 8.51% | 6 | -50.00% | 4 | 300.00% |
30 Sep, 22 | 20 | 33.33% | 7,283,589 | 5.12% | 3.92% | 28.22% | 12 | 140.00% | 1 | -66.67% |
30 Jun, 22 | 15 | - | 6,928,902 | -14.27% | 3.72% | 19.73% | 5 | 66.67% | 3 | -25.00% |
31 Mar, 22 | 15 | -6.25% | 8,082,294 | 0.25% | 4.34% | 23.13% | 3 | -57.14% | 4 | 100.00% |
31 Dec, 21 | 16 | 14.29% | 8,062,390 | 4.55% | 4.33% | 25.22% | 7 | 16.67% | 2 | - |
30 Sep, 21 | 14 | -12.50% | 7,711,585 | 120.01% | 4.15% | 65.65% | 6 | -25.00% | 2 | -50.00% |
30 Jun, 21 | 16 | 6.67% | 3,505,165 | -7.67% | 2.51% | 33.92% | 8 | 60.00% | 4 | 33.33% |
31 Mar, 21 | 15 | -6.25% | 3,796,316 | 12.40% | 2.72% | 46.42% | 5 | - | 3 | -25.00% |
31 Dec, 20 | 16 | 6.67% | 3,377,498 | -16.63% | 2.42% | 28.70% | 5 | -16.67% | 4 | 33.33% |
30 Sep, 20 | 15 | -11.76% | 4,051,309 | 76.18% | 2.90% | 106.87% | 6 | -53.85% | 3 | 200.00% |
30 Jun, 20 | 17 | 88.89% | 2,299,515 | 49.91% | 1.65% | 136.32% | 13 | 333.33% | 1 | -66.67% |
31 Mar, 20 | 9 | -10.00% | 1,533,971 | 23.74% | 1.10% | 139.24% | 3 | -25.00% | 3 | - |
31 Dec, 19 | 10 | -16.67% | 1,239,642 | 1.85% | 0.89% | 116.72% | 4 | -33.33% | - | - |
30 Sep, 19 | 12 | 20.00% | 1,217,178 | 7.33% | 0.87% | 64.82% | 6 | 50.00% | - | -100.00% |
30 Jun, 19 | 10 | 11.11% | 1,134,079 | 12.47% | 1.16% | 109.01% | 4 | - | 3 | 50.00% |
31 Mar, 19 | 9 | -10.00% | 1,008,372 | 96.12% | 1.03% | 372.85% | 4 | -42.86% | 2 | 100.00% |
31 Dec, 18 | 10 | 66.67% | 514,159 | 191.74% | 0.53% | 1618.08% | 7 | 600.00% | 1 | - |
30 Sep, 18 | 6 | -25.00% | 176,237 | 1.56% | 0.18% | 572.17% | 1 | -80.00% | 1 | - |
30 Jun, 18 | 8 | 14.29% | 173,534 | 9.53% | 0.18% | 675.69% | 5 | -28.57% | 1 | - |
31 Mar, 18 | 7 | - | 158,432 | - | 0.16% | - | 7 | - | - | - |
Tenax Therapeutics Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
Insider Sells
All Insider Owners Trades
The last insider sell of Tenax Therapeutics's stock was made by HOFFMAN LAWRENCE R on Jan 12 2024, selling - shares at - per share (valued at -). The last insider buy of TENX was made by PROEHL GERALD T on Aug 08 2024, buying 31,654 shares at $0.01 per share (worth $316.54).
Tenax Therapeutics Insider Ownership Trends
All Insider Trades Trend
Date | Buy | Sell | Buy/Sell Ratio |
---|---|---|---|
Q3 2024 | 6 | - | - |
Q2 2024 | 2 | - | - |
Q1 2024 | - | 1 | - |
Q3 2022 | 1 | 2 | 50.00% |
Q2 2022 | 13 | 1 | 1300.00% |
Q1 2022 | - | 1 | - |
Q4 2021 | 2 | 3 | 66.67% |
Q3 2021 | 3 | 1 | 300.00% |
Q2 2021 | 8 | 4 | 200.00% |
Q1 2021 | 5 | 5 | 100.00% |
Q3 2020 | 26 | 4 | 650.00% |
Q2 2020 | 5 | - | - |
Q1 2020 | 2 | 1 | 200.00% |
Q2 2019 | 1 | - | - |
Q4 2018 | - | 1 | - |
Q3 2018 | 1 | - | - |
Q2 2018 | 5 | - | - |
Q1 2018 | 1 | - | - |
Q4 2017 | 3 | 1 | 300.00% |
Q3 2017 | 1 | - | - |
6 total buy trades, and 0 total sell trades (buy/sell ratio of 0%) were made by Tenax Therapeutics's insiders, as of Q3 2024.
Open Market Insider Trades Trend
Date | Buy | Sell | Buy/Sell Ratio |
---|---|---|---|
Q3 2024 | 6 | - | - |
Q2 2024 | - | - | - |
Q1 2024 | - | - | - |
Q3 2022 | - | - | - |
Q2 2022 | - | - | - |
Q1 2022 | - | - | - |
Q4 2021 | - | - | - |
Q3 2021 | - | - | - |
Q2 2021 | - | - | - |
Q1 2021 | - | - | - |
Q3 2020 | 26 | - | - |
Q2 2020 | 1 | - | - |
Q1 2020 | - | - | - |
Q2 2019 | - | - | - |
Q4 2018 | - | - | - |
Q3 2018 | - | - | - |
Q2 2018 | - | - | - |
Q1 2018 | - | - | - |
Q4 2017 | 2 | 1 | 200.00% |
Q3 2017 | - | - | - |
As of Q3 2024, Insider owners conducted 6 open market buy trades and 0 open market sell trades of Tenax Therapeutics's stocks.
Tenax Therapeutics Peer Ownership
Ticker | Company |
---|---|
ZVSA | ZyVersa Therapeutics, Inc. |
BWV | Onconetix, Inc. |
ENSC | Ensysce Biosciences, Inc. |
PXMD | PaxMedica, Inc. Common Stock |
ADTX | Aditxt, Inc. |
REVB | Revelation Biosciences, Inc. |
QNRX | Quoin Pharmaceuticals, Ltd. |
HILS | Tharimmune, Inc. |
DRMA | Dermata Therapeutics, Inc. |
VRAX | Virax Biolabs Group Limited |
ALLR | Allarity Therapeutics, Inc. |
CYTO | Altamira Therapeutics Ltd. |
NRBO | NeuroBo Pharmaceuticals, Inc. |
SONN | Sonnet BioTherapeutics Holdings, Inc. |
WINT | Windtree Therapeutics, Inc. |
UNCY | Unicycive Therapeutics, Inc. |
BXRX | Baudax Bio, Inc. |
TENX Ownership FAQ
Who Owns Tenax Therapeutics?
Tenax Therapeutics is owned by institutional shareholders (1.31%), insiders (0.33%), and public (98.37%). The largest institutional shareholder of Tenax Therapeutics is CI PRIVATE WEALTH, LLC (13.62% of total shares) and the top mutual fund owner is VANGUARD INDEX FUNDS (0.00% of total shares).
Who are the major institutional shareholders of Tenax Therapeutics?
Tenax Therapeutics's major institutional shareholders are CI PRIVATE WEALTH, LLC, STATE STREET CORP, VIRTU FINANCIAL LLC, VERITION FUND MANAGEMENT LLC, and TWO SIGMA SECURITIES, LLC. The top five shareholders own together 32.54% of the company's share outstanding.
How many Tenax Therapeutics shareholders are there?
As of Dec 2022, there are 15 institutional shareholders of Tenax Therapeutics.
What percentage of Tenax Therapeutics is owned by CI PRIVATE WEALTH, LLC?
CI PRIVATE WEALTH, LLC owns 191.46K shares of Tenax Therapeutics, representing 13.62% of the company's total shares outstanding, valued at $89.03M (as of Mar 2023).
What percentage of Tenax Therapeutics is owned by STATE STREET CORP?
As of Mar 2023, STATE STREET CORP holds 95.12K shares of Tenax Therapeutics (TENX), compromising 6.77% of the company, valued at $44.23M.
What percentage of Tenax Therapeutics is owned by VIRTU FINANCIAL LLC?
VIRTU FINANCIAL LLC is the third largest holder of Tenax Therapeutics. The company owns 84.36K of the company's shares outstanding (worth $39K).